Ron Najafi

Dr. Ramin (“Ron”) Najafi is the founder, chairman and CEO of NovaBay Pharmaceuticals (NYSE-Amex: NBY), a clinical stage biopharmaceutical company developing first-in-class anti-infectives for treating and preventing antibiotic-resistant infections. An accomplished entrepreneur and scientist, Dr. Najafi has founded three companies, and has held numerous executive and scientific roles in the biopharmaceutical industry over the past 20 years.